Treatment of Necrotizing Fasciitis with Documented Vibrio vulnificus

Necrotizing fasciitis (NF) can present as a monomicrobial infection. When Vibrio vulnificus is the confirmed causative organism, the treatment strategy is adjusted to target this specific pathogen once the microbial etiology is established.

Clinical Scenario

This protocol applies to cases of necrotizing fasciitis in which Vibrio vulnificus has been documented as the causative agent. NF may be monomicrobial — caused by organisms such as Vibrio vulnificus — or polymicrobial. Once the microbial etiology is confirmed, antibiotic coverage should be appropriately modified to reflect the identified pathogen.

Treatment Approach

Management requires urgent surgical intervention combined with an antibiotic regimen specifically directed against Vibrio vulnificus. The regimen involves a combination of antibiotic classes; the full agent selection, dosing, and sequencing are detailed in the complete protocol.

Full antibiotic regimen — including agents, doses, and duration — is available in the structured protocol below.

Treatment Goals

The endpoint of therapy is clinical improvement and the absence of fever for 48–72 hours, alongside resolution of the need for further surgical debridement.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1093/cid/ciu296
They can be monomicrobial, usually from streptococci or less commonly community-acquired MRSA, Aeromonas hydrophila, or Vibrio vulnificus, or polymicrobial, involving a mixed aerobe-anaerobe bacterial flora.
Once the microbial etiology has been determined, the antibiotic coverage should be appropriately modified.
In the absence of definitive clinical trials, antimicrobial therapy should be administered until further debridement is no longer necessary, the patient has improved clinically, and fever has been absent for 48-72 hours.

View source ↗